Member Info for Cliostock

Bel, the same thing clicked with me recently and I came to the conclusion that it is probably the biggest downside to SBTX right now; the fact that a good chuck of the stock is held by someone who probably doesn’t want to see it roar ahead. It really is up to SA and his team to make Skin such a good proposition that he can’t hold it back if he wanted to - I believe our team are getting there with achieving this.

There is also the fact that the OPTI shareholders should rightly crucify SOH for selling any more skin. It appears a jewel in their crown whilst their own operations continue to, at best, tread water. I do really feel for those OPTI investors that have supported up to yesterday. I hope our team continue to keep the pace lest we be tarred with that same brush by close association.

Trader I think TW said something along the lines of the Croda deal potentially being worth the current market cap, some improved axis sales could make AxisBiotix worth the current market cap and a great oral deal could be worth the current market cap. I know that wouldn’t quite put us at 100p but all three are due substantially sooner than 18 months, so I think your prediction could work out to be very realistic.

Also agree with you trader. Hopefully OPTI investors will see that SBTX may be a good method of earning their OPTI losses back and buy in here. At least SBTX has plenty of good developments going for it, I can’t see much good happening at OPTI, and what is good is tarnished with risk due to previous performance. Why anyone would be in there and not in here baffles me.

Never a dafter thing said

Yep looks like about 665k shares sold today up-to press. But we’ve all been here on days where that many shares have been bought and it moves just as quickly the other way. It’s the nature of the beast. All this volatility will get more eyes on the share so if we get the update we are all hoping I’d be hoping for way more buys than there has been sells today.

Looks like someone is kicking batches of 50k shares out of the door at a time. Nice to see some supportive buys picking up the cheaper shares.

Most long term holders that know this company well know that there could be several good things just around the corner, but with no sign of the updates you can’t blame people for jumping ship if they see a better opportunity elsewhere. I hope the team are planning to release some news soon, it’s hard to watch the SP slip. I understand if there is nothing RNS-able at this very moment but an interview with Elric or TW wouldn’t go amiss, SA regularly compliments himself (quite rightly) about the dynamic way the company is run and how it adapts to challenges and works ahead of schedule. For this reason I think there must be plenty happened in the past 5 months of him “breaking his back” to achieve the forecast amount, so if there is nothing RNS worthy then a general interview offering non price sensitive insight would be appreciated.

Good spot on trustpilot Toyin, we were told early on that the company would look to ship in bulk to regions then distribute from within the region for efficiency. Sounds like we could be reaching that point with the U.K. market.

Retention rates were circa 80% at the last update but it has been said that this could swing a little bit. It’s a great stat but I’m personally not putting too much hope on it staying quite that high as word spreads. I’d hate to see the market upset because it has dropped slightly to 70 or 75%, when in reality the more well known the product gets the more likely it is to drop slightly. Anything over 50% is good IMHO.

Hi BP, in fairness to the management they did tell us they were planning a soft launch before they launched, it wasn’t an excuse thought of later to justify the sales.

I think the real truth is that they didn’t anticipate just how soft the launch would be, I imagine a good amount of the 22k sales we’re probably investors wanting to see the product. Given the logistically issues it seemed to work out well that sales were limited and it also gave the management chance to build a B2C team to allow the business to function having a B2C arm. When the product was launching SBTX had a team of 3. That’s pretty amazing and I certainly don’t blame Stuart for not using 16 methods of marketing. I also think that explains where the SP is today, and there is some real potential for a strong increase in SP once we have news sales have improved and we start to see updates on the many irons that this company has in the fire. As Toyin said, when the share price dropped to this sort of level with a product on the market and Croda royalties drawing closer it was like Christmas, and I bought lots of shares at 22p.

Toyin, you told him he was obviously either a trouble maker or stupid. Someone else told him to sell his shares and move on. His questions show unfamiliarity with the company but weren’t unreasonable. I understand that the ham-fisted assumptions such as saying Stuart’s strategy is ‘not good enough given the cost of our executive’ can be irritating, but the company comes off better if we explain our rationale, which we can do with ease. If people can’t be bothered, there is no need to hit reply. I appreciate you tried to help out first but posting the YouTube videos which would be really very helpful if he chose to study them. This company has nothing to hide and is really well run, we regulars can explain most things reasonably using our huge amount of background knowledge which is hard to obtain over a short time for a new investor, but at times like these new blood can help maintain the SP until news.

Hi Bigpunt, I’m sorry to see you have come new to the board to receive some unfriendly responses. I can empathise, as I have been in your position quite recently, posting a few warranted and well thought out but pressing questions on a different company board, and I also received some defensive comments and accusations of causing trouble. I was looking at a starting investment of 10k there and I just wanted some information I couldn’t find elsewhere. I didn’t bother.

I agree with my comrades that Stuart Ashman is a great CEO and I do disagree with your concerns that he may be single minded when it comes to marketing. The comments I would like to add are:
1.) I do feel Stuart and the company were led up the garden path by both the U.K. and US Psoriasis associations. Before launch they were calling each other partners, Stuart said in an interview once that they had applied pressure for the company to make their Psoriasis formula first, that they had been involved with advising on pricing and that the Psoriatic community were very vocal and therefore the product could be launched frugally with not a great deal of marketing spend. None of this transferred into many early sales, as evidenced by the 22k sales in the first two months even though the members of the associations had access to sign up during this time. Stuart will have had to pivot to the influencer strategy and later the national press advertising and social media managers, but sadly this didn’t happen in time to save the numbers.
2.) The launch of the product was purposely ‘soft’, and with good reason. Sending little packets of unknown white powder by post from an hour outside of Amsterdam was expected to, and did, cause lots of headaches. Stuart didn’t want to kick off with bad reviews and interrupted supplies so purposely didn’t have a huge launch made up of lots of channels of marketing.

I do think that now, with a little patience, that the AxisBiotix PS sales will be good. I also think that when the acne formula is complete it will blow it out of the water because it is so marketable, and remember, we have Geoff Bell on the team (Google shampooheads) who is experienced at marketing to the Acne age group.

This company has a huge amount going for it, even if you don’t invest yet make sure you hang around and soak up the events and I think from that you will learn all you wish to know about Stuart and the way he does things.

I hope it’s good, i spend a fortune on Aveeno just for general dry skin. Happy to switch that allegiance!

That’s not a consideration I’d ever made, nor one I’ve ever been told. Every day is a school day, as they say.

Hopefully won’t be too long, even if it’s just a general business update. The company is usually fairly communicative with shareholders so I’m sure some kind of update will be on the cards soon. We know the management team have been on with a hell of a lot so I’d imagine the longer we have to wait, they more they have to say.

Mad, you’re right it was a bit strong and I apologise. I think I was incensed at the thought of new investors seeing Farris’s comment and actually thinking a fundraise might be on the cards here, it’s enough to put people off. You are right in that if there was a fundraise, one would hope there was a good reason for it and I’ve always been a staunch supporter of SA, I do firmly believe he is a cut above other AIM CEO’s. There is an element of expectation placed on SA though, because of the way he talks about the potential of the business and the way it is run. I still think a fundraise for any reason off the back of a horrendous share price crash is not prudent here, I would first expect some of the dangling carrots to be harvested to restore the share price.

I think I can say with some confidence the company does not need to fundraise. Plenty of cash in the bank, conservative management, growing high margin sales, soon to be receiving royalty payments and possible upcoming agreements with signing on and milestone payments. If SA announced a fundraise at this level at this time I would renounce all I have said about my confidence in him being an excellent CEO and turn my back in disgust. And I really like this company!

Oleric I would say the update we are waiting for from the oral study is if it has revealed anything which becomes a commercial opportunity. That’s about it at this stage.

There could well be something soon, just because it’s been over 4 months since the last update/trading statement, and there is so much that could possibly be said.

Don’t get me wrong, I’m happy to wait until the time is right for the company to release, but I don’t see how we can be too far away from something or other now.

“We have improved skin penetration by more than nine times”

This is also the part that piqued my interest. Could this be the additional claim that we were told Croda was working on? Elric, now it’s has been in a Croda RNS can our company inform us about it?

Re the Croda news, Stuart said in one of his interviews something about the earliest we might hear something is if Croda releases a marketing pack for the product which could be the end of the summer. That’s around the end of September. He also said it takes 90 days to write up the paper so I thought he was preparing us for a wait there. I personally think the next news will be something to do with Axis sales.

No problem Oke, welcome to the board, I’m very jealous if you’re getting in for the first time at 24p!